4,5-Diaryl 3(2H)Furanones: Anti-Inflammatory Activity and Influence on Cancer Growth
Apart from their anti-inflammatory action, COX inhibitors have gathered the interest of many scientists due to their potential use for the treatment and prevention of cancer. It has been shown that cyclooxygenase inhibitors restrict cancer cell growth and are able to interact with known antitumor drugs, enhancing their in vitro and in vivo cytotoxicity. The permutation of hydrophilic and hydrophobic aryl groups in COX inhibitors leads to cardinal changes in the biological activity of the compounds. In the present study, thirteen heterocyclic coxib-like 4,5-diarylfuran-3(2H)-ones and their annelated derivatives—phenanthro[9,10-b]furan-3-ones—were synthesized and studied for anti-inflammatory and COX-1/2 inhibitory action and for their cytotoxic activity on the breast cancer (MCF-7) and squamous cell carcinoma (HSC-3) cell lines. The F-derivative of the –SOMe substituted furan-3(2H)-ones exhibited the best activity (COX-1 IC50 = 2.8 μM, anti-inflammatory activity (by carrageenan paw edema model) of 54% (dose 0.01 mmol/kg), and MCF-7 and HSC-3 cytotoxicity with IC50 values of 10 μM and 7.5 μM, respectively). A cytotoxic effect related to the COX-1 inhibitory action was observed and a synergistic effect with the anti-neoplastic drugs gefitinib and 5-fluorouracil was found. A phenanthrene derivative exhibited the best synergistic effect with gefitinib.
Citations by journals
1
|
|
Journal of Physical Organic Chemistry
|
Journal of Physical Organic Chemistry
1 publication, 10%
|
Royal Society Open Science
|
Royal Society Open Science
1 publication, 10%
|
Journal of Organic Chemistry
|
Journal of Organic Chemistry
1 publication, 10%
|
Molecules
|
Molecules
1 publication, 10%
|
Frontiers in Microbiology
|
Frontiers in Microbiology
1 publication, 10%
|
Journal of the Iranian Chemical Society
|
Journal of the Iranian Chemical Society
1 publication, 10%
|
Medical Oncology
|
Medical Oncology
1 publication, 10%
|
Pharmacological Research - Modern Chinese Medicine
|
Pharmacological Research - Modern Chinese Medicine
1 publication, 10%
|
New Journal of Chemistry
|
New Journal of Chemistry
1 publication, 10%
|
Journal of Molecular Liquids
|
Journal of Molecular Liquids
1 publication, 10%
|
1
|
Citations by publishers
1
2
|
|
Springer Nature
|
Springer Nature
2 publications, 20%
|
Elsevier
|
Elsevier
2 publications, 20%
|
Wiley
|
Wiley
1 publication, 10%
|
The Royal Society
|
The Royal Society
1 publication, 10%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
1 publication, 10%
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
1 publication, 10%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
1 publication, 10%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
1 publication, 10%
|
1
2
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.